The HEADWIND Study - Part 4

NCT05308095 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators